BioSpace News Archive

Vetter has recently become a participant of the UN Global Compact Network (UN GC). The globally operating Contract Development and Manufacturing Organization (CDMO) is one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices.

Protect Pharmaceutical Corp. “OTC:(PRTT)” announces the change of control of the Preferred series A shares and the appointment of a new president, Ali Yildiz.

Researchers at Boston Children’s Hospital and Harvard Medical School’s Department of Neurobiology have developed a new approach to measure dynamic changes in behavior in an unbiased, observer-independent manner, according to a new study published in and featured on the cover of PAIN, the journal of the International Association for the Study of Pain (IASP).

BIORCHESTRA today announced that it will be participating in two upcoming therapeutic RNA-focused events.

Anika Therapeutics, Inc. announced it is highlighting recently-launched products in high growth segments of joint preservation and restoration at the 2023 American Academy of Orthopedic Surgeons Annual Meeting on March 8-10 in Las Vegas, NV.

SYNAPS Dx is pleased to announce that the Advanced Neurology, Epilepsy and Sleep Centers with locations in the El Paso, Texas area will be among the first in the country to offer area residents access to DISCERN™, a minimally invasive diagnostic test.

Medivir AB announces that the company will participate at the Stockholm Corporate Finance Life Science Day on March 9, 2023.

FK LiveLabs - Agile Market Research is proud to announce a collaboration with DemDx - the leading patient AI-enabled clinical pathway app for HCPs.

PACT Pharma, Inc. today announced the publication of a peer-reviewed paper in Nature in collaboration with researchers at University of California, Los Angeles (UCLA) detailing groundbreaking work characterizing and differentiating the immune responses of melanoma patients treated with anti PD-1 immunotherapy.

The Society of Vascular and Interventional Neurology (SVIN) has released a first-ever global analysis of access to mechanical thrombectomy (MT) for treatment of large vessel occlusion (LVO) stroke, as part of the SVIN Mission Thrombectomy study, Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study, published in the American Heart Association Circulation journal.